Results 21 to 30 of about 31,072 (141)
Association of Alopecia Universalis, Generalized Vitiligo, and Graves' Disease
We present a 21-years old woman with alopecia universalis, generalized vitiligo, and Graves' disease. She had had thyroidectomy in early childhood and was receiving replacement therapy with levothyroxine.
Z Shahmoradi +2 more
doaj +1 more source
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis [PDF]
Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes surround the basis of the follicles, inducing loss of pigmented terminal hair and subsequently inhibit further hair growth.
Florian Anzengruber +5 more
doaj +2 more sources
A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib [PDF]
Zhao J, Liu L.
exaly +2 more sources
Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222) [PDF]
Jonathan Ho
exaly +2 more sources
Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Myeloproliferative disorder associated with alopecia universalis [PDF]
Mardeen S. Karim, MD +2 more
doaj +2 more sources
Highly active antiretroviral therapy has contributed to an increase of Human Immunodeficiency Virus (HIV) seropositive patients life expectancy. Because of that, comorbidities spectrum associated to this disease has been changing.
Marta Nobre Pereira +1 more
doaj +1 more source
Treatment of alopecia universalis with oral alitretinoin: A case report
Pierre-Olivier Grenier, MD +1 more
exaly +3 more sources
Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Limited data concerning the development of autoimmune skin diseases after COVID-19 vaccination are currently available. Recently, a few reports described the development, worsening or recurrence of alopecia areata after the administration of COVID-19 ...
Francesco Tassone +5 more
doaj +1 more source
Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature [PDF]
Janus kinase inhibitors are emerging treatment alternatives in various immune-mediated diseases including alopecia universalis. Herein, we report a patient with psoriasis and alopecia universalis in whom treatment with tofacitinib led to remission of ...
Salman, Andac +2 more
core +2 more sources

